Maria I. Carlo - Concepedia

Author

Maria I. Carlo

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Carlo, Maria, Carlo, Maria I, Carlo, Maria I., M. Carlick, M. Carlo, M. I. Carlo, M.I. Carlo, Maria Carlo, Maria I Carlo, Maria I. Carlo

260

Publications

7.4K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University Molecular Oncology (United States)University of Pennsylvania The University of Texas MD Anderson Cancer Center

About

Maria I. Carlo is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, urology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	29	2.4K
2	Immunology	5	5	501
3	Public Health	2	2	131
4	Cell Biology	2	2	936
5	Molecular Medicine	1	1	17

Maria I. Carlo

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Journal of the National Comprehensive Cancer Network	2022	627
Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer Alicia Latham, Preethi Srinivasan, Yelena Kemel, Journal of Clinical Oncology	2018	603
Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers Min Yuen Teo, Kenneth Seier, Irina Ostrovnaya, Journal of Clinical Oncology Higher Response RatePathologyTumor BiologyPd-1/pd-l1 BlockadeGenitourinary Cancer	2018	528
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing Diana Mandelker, Liying Zhang, Yelena Kemel, JAMA	2017	504
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy Chirag Krishna, Renzo G. DiNatale, Fengshen Kuo, Cancer Cell Therapy EfficacyCancer ImmunosurveillanceT-regulatory CellImmunologyTumor Immunity	2021	408
NCCN Guidelines Insights: Kidney Cancer, Version 1.2021 Robert J. Motzer, Eric Jonasch, Shawna Boyle, Journal of the National Comprehensive Cancer Network UrologyGenitourinary CancerStage Iv RccMedicineKidney Research	2020	247
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma Maria I. Carlo, Semanti Mukherjee, Diana Mandelker, JAMA Oncology	2018	191
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates Chung‐Han Lee, Martin H. Voss, Maria I. Carlo, Journal of Clinical Oncology	2022	182
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors Elise Fiala, Gowtham Jayakumaran, Audrey Mauguen, Nature Cancer Tumoral PathologyMedicineCancer ManagementPathologyPediatric Solid Tumors	2021	156
Therapeutic Implications of Germline Testing in Patients With Advanced Cancers Zsofia K. Stadler, Anna Maio, Debyani Chakravarty, Journal of Clinical Oncology	2021	145

Page 1